Screening360 2026: Advancing Diagnostic Screening Through Imaging, Pathology & AI
Book tickets
Screening360 2026: Advancing Diagnostic Screening Through Imaging, Pathology & AI
A Strategic Summit on Advancing Diagnostic Screening Through Imaging, Pathology & AI - All Convenzis Events Provide 8 CPD Points Per Delegate
Take part in our conference prize draw by visiting all stands and scanning your lanyard at each for a chance to win £100 voucher.
Sponsors & Partners
Current Landscape and Challenges
NHS screening programmes are central to the shift towards prevention and early diagnosis, yet delivery at scale remains inconsistent. Rising demand, workforce shortages and increasing diagnostic backlogs are placing significant strain across imaging, pathology and community screening services.
At the same time, systems are being asked to expand access, reduce inequalities and accelerate diagnosis across key pathways including cancer, cardiovascular and long term conditions. Screening programmes such as breast and cervical are under increasing pressure to improve uptake, turnaround times and diagnostic accuracy while maintaining public trust and clinical safety.
Fragmented data flows, limited interoperability and variable digital maturity continue to slow progress. The introduction of AI into screening pathways presents a significant opportunity, but also introduces new challenges around governance, workforce confidence and safe deployment at scale.
The challenge is no longer understanding what needs to change, but how to implement integrated, AI enabled and workforce sustainable screening models across imaging, pathology and population health systems.
Timeliness of the Event
With national focus intensifying on prevention, early detection and population health management, screening is now a critical lever for improving outcomes and reducing pressure on acute services.
AI enabled diagnostics, community diagnostic centres and targeted screening initiatives are already being deployed across the NHS, particularly within high impact areas such as breast and cervical screening. However, variation in adoption, pathway design and operational delivery remains significant.
There is a clear need to move beyond pilots and isolated innovation towards standardised, system wide implementation. This includes aligning imaging, pathology and digital infrastructure, while ensuring governance, safety and workforce readiness are embedded from the outset.
Screening360 2026 provides a timely platform for NHS leaders to understand what is working in practice, learn from early adopters and accelerate the delivery of scalable, equitable and clinically robust screening services.
Key Learning Outcomes
- How to implement AI enabled screening workflows across imaging and pathology while maintaining clinical safety and governance.
- Practical delivery models for high impact screening pathways including breast, cervical and cancer diagnostics.
- Approaches to integrating imaging, pathology and data systems to support faster and more accurate diagnosis.
- How to expand screening capacity through community based and population health driven models.
- Workforce strategies including skill mix, automation and decision support to increase throughput without increasing burnout.
- Governance frameworks required to deploy AI safely, manage risk and build clinical and public confidence.
- Lessons learned from NHS organisations moving from pilot to operational screening delivery at scale.
Why Attend
Screening360 2026 is designed for NHS leaders responsible for delivering screening and diagnostic transformation across real world pathways. This is not a high level policy discussion, it is a practical forum focused on how to operationalise screening at scale.
With a strong focus on high impact areas such as cancer screening and women’s health pathways, the event brings together imaging, pathology and digital leaders to share what is working, what has failed and what needs to change.
Delegates will leave with tangible outputs including implementation frameworks, governance checklists and real world delivery models that can be applied immediately within their own systems. Through skill clinics, NHS deep dives and frontline reflections, attendees will gain the clarity and confidence needed to expand capacity, improve early detection and deliver measurable improvement in patient outcomes.
Relevance for Sponsors & Partners
This conference provides a highly targeted platform for organisations supporting diagnostic screening, early detection and pathway improvement across imaging, pathology and AI-enabled diagnostics.
Sponsors will be well-positioned to demonstrate how their solutions enable:
- Screening technologies supporting earlier detection across cancer, women’s health, lung, prostate and wider diagnostic pathways.
- Imaging, pathology and laboratory solutions that improve screening accuracy, reporting capacity and diagnostic turnaround times.
- AI-enabled detection, risk stratification and decision-support tools that help prioritise patients and improve clinical workflow.
- Digital pathology, image management and data platforms supporting scalable screening programmes and multidisciplinary review.
- Patient engagement, self-sampling and access solutions that improve participation, inclusion and uptake in screening services.
- Workforce, workflow and capacity solutions that help screening teams manage demand, reduce backlog and support sustainable delivery.
- Governance, quality assurance and evaluation tools that help NHS teams move from pilot activity into safe, measurable implementation.
Your Pass Includes....
- This conference is CPD accredited. Attendees will be eligible to gain 8 CPD points upon completion of the event.
- Access to a leading conference speaker programme
- Interactive Q&A sessions
- Leadership Lessons from the Front Line
- Cross-sector best practice
- Meet the supplier opportunities
- Hot breakfast & Lunch included
- Access to post event drinks reception and Street food
Tickets For NHS Senior Managers
We have an invite only option for NHS Senior Managers for our conference, to see if you qualify for a complimentary place please click the button below.
Conference Speakers
Kevin
Moore
Professor of Hepatology
University College London & Royal Free London Foundation Trust
Read biography
The programme
Registration & Networking
Registration - Open from 8:20 am - Closes at 11:00 am
All delegates must complete their registration process before the 11:00 AM cut-off time. Please arrive in a timely manner to allow for registration and to avoid any inconvenience. Delegates who arrive after the registration deadline will be refused entry to the event.
We appreciate your cooperation in helping us maintain the event's schedule and ensuring that everyone can fully participate in the conference. If you have any questions or require assistance, our event staff will be available to assist you with the registration process.
Thank you for your understanding, and we look forward to an insightful and productive event together!
Chair Opening Address
Welcome, introduction to Screening360 and framing of the day.
Opening Keynote - The Future of NHS Screening: From Population Programmes to Earlier, Smarter and More Personalised Detection
Session Overview:
The presentation will be a physician’s perspective on advancing the use of pathology and imaging for long-term surveillance, screening, case-finding and early diagnosis. He will illustrate the value of digital tools to make patients safer, reduce wait times in clinic, and create space for clinicians to connect to their patients.
Key Learning:
- Why bother? The value of long-term monitoring, screening or case finding studies? How early diagnosis saves lives.
- How can we make screening or surveillance cost effective, safer and automated, whilst creating more capacity in outpatients at lower cost?
- Pathology is the largest early-warning system in the NHS, but we often miss its signals. We need diagnostic orchestration as well as capacity, and to recognize the signals. By connecting the dots we can create more effective tools.
THE CUTTING EDGE OF SCREENING SERVICES
New Models for Prevention, Earlier Detection & Population Health
A focused double-presentation exploring two very different approaches to taking screening and earlier detection beyond traditional models. From targeted cancer detection delivered directly within communities to more integrated women's health services, the sessions will examine how prevention, access and earlier intervention can be redesigned around the needs of populations.
NHS Deep Dive : Taking Early Detection into the Community: Lessons from the Man Van
Professor Nick James, Professor of Prostate and Bladder Cancer Research, The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust (provisionally confirmed)
Traditional routes into cancer diagnosis do not always reach those at greatest risk. The Man Van programme has taken prostate health checks and wider men's health interventions directly into communities, providing a different model for identifying higher-risk individuals and improving access to earlier investigation.
Professor Nick James will share the practical experience behind the programme, exploring how targeted community outreach can engage underserved populations, identify cancer risk earlier and connect individuals effectively into onward diagnostic pathways.
The session will consider what has been learned about participation, inequalities, targeting higher-risk populations and the potential for community-based approaches to complement established NHS screening and early-diagnosis services.
NHS Deep Dive - Rethinking Women's Health: Connecting Prevention, Screening and Earlier Diagnosis
Professor Eugene Oteng-Ntim, Clinical Director for Women's Services, Guy's and St Thomas’s NHS Foundation Trust (provisionally confirmed)
Women's health services often span multiple parts of the NHS, creating challenges around access, referral, prevention and earlier diagnosis. Developing more integrated models provides an opportunity to bring services closer together and intervene earlier.
Professor Eugene Oteng-Ntim will explore how women's health pathways can become more proactive, accessible and joined-up, connecting primary, community and specialist services around the needs of women rather than traditional organisational boundaries.
The session will consider screening and prevention, inequalities in access, earlier intervention and the development of integrated women's health pathways, alongside what wider NHS services can learn from emerging models of women's health delivery.
Expert Q&A: What Comes Next for NHS Screening and Earlier Detection?
Kevin Moore, Professor Nick James & Professor Eugene Oteng-Ntim
A short, chaired discussion bringing together the morning speakers to consider how NHS screening must evolve as services move towards more targeted, community-based and preventative approaches.
Discussion:
How do we reach people traditional models miss? Where should targeted approaches complement population screening? How can inequalities be reduced? And what should NHS screening and prevention services prioritise next?
Main Sponsor
Main Sponsor
Morning Break
Got a great question? Ask it during the session for a chance to win a voucher for the best audience question.
Case Study
Case Study
Case Study
Case Study
Lessons Learnt from the Frontline - Expanding Capacity Without Expanding Workforce
The RPA work is a great anchor for this, particularly around:
- Reducing manual burden across diagnostic pathways.
- Improving throughput without additional workforce.
- Lessons from moving beyond pilot into real operational use.
- Adoption, governance and scaling challenges.
Case Study
Case Study
Lunch & Networking
Got a great question? Ask it during the session for a chance to win a voucher for the best audience question.
Case Study
Case Study
NHS Deep Dive - Expanding Screening Capacity Without Expanding Workforce: A Practical NHS Approach
Session Overview:
With workforce growth constrained, services are under increasing pressure to deliver higher screening volumes without increasing staff burden.
This session explores how organisations are redesigning workforce models, introducing advanced practice roles and using decision support to increase capacity. Drawing on real-world experience from cancer pathways, the focus is on improving throughput while maintaining staff wellbeing and clinical safety.
Key Learning:
- Workforce models that support higher volume screening delivery.
- The role of advanced practice and skill mix redesign.
- How services are balancing productivity with workforce wellbeing.
- Practical examples of pathway redesign in cancer screening.
Presentation - Transforming Women’s Health Screening: Improving Access, Uptake and Earlier Diagnosis
Session Overview:
Women’s health screening services are under growing pressure to improve participation, reduce inequalities and deliver earlier diagnosis across breast and cervical pathways. At the same time, workforce constraints, regional variation and increasing demand continue to create practical challenges for services responsible for delivering screening at scale.
This session will explore how NHS organisations are redesigning women’s health screening pathways to improve access, strengthen uptake and support more timely diagnosis. It will consider the role of community delivery, advanced practice, imaging, digital tools and targeted engagement in creating more equitable and sustainable screening models.
The focus will remain on practical delivery, including what is working, where barriers remain and what NHS leaders should prioritise next.
Key Learning:
- Practical approaches to improving participation and reducing inequalities.
- How services are strengthening breast and cervical screening pathways.
- The role of workforce redesign, imaging and digital tools in expanding capacity.
- Lessons from delivering more accessible, equitable and sustainable screening services.
NHS Deep Dive - AI in Screening: The Critical Role of Pathology Services
Session Overview:
Artificial intelligence is increasingly being integrated into screening programmes to improve accuracy, efficiency, and early disease detection. While much focus is placed on algorithm development, pathology services play a central role in ensuring safe and effective implementation. This presentation highlights the importance of pathology in AI-driven screening, particularly in providing diagnostic ground truth, supporting model validation, and ensuring data quality. It also explores the integration of digital pathology into routine workflows and how AI may assist in managing high diagnostic workloads. Key challenges including validation, bias, governance, and regulatory requirements are discussed, alongside the evolving role of the pathologist in an AI-enabled healthcare system. The session concludes by emphasising the need for close collaboration between clinicians, pathologists, and data scientists to ensure safe, reliable, and equitable screening outcomes.
Afternoon Skills Clinic - Closing the Gaps in NHS Screening: Access, Capacity and Earlier Diagnosis
Panellists:
- Josh Soane, Cancer Access, Mid and South Essex NHS Foundation Trust
- Speaker TBC - Screening / Public Health Leadership
- Speaker TBC - Imaging / Diagnostic Pathway Leadership
Session Overview:
As NHS screening services expand and evolve, improving outcomes will depend not only on new technologies and screening models, but on addressing the practical barriers that prevent people from accessing services and moving efficiently through diagnostic pathways.
This panel will explore the challenges currently affecting screening delivery across the NHS, including inequalities in participation and uptake, workforce and diagnostic capacity, variation between services, and delays between screening, investigation and onward care.
Bringing together perspectives from screening, cancer services, diagnostics, public health and pathway leadership, the discussion will consider how organisations can create more accessible, connected and sustainable screening pathways while responding to increasing demand.
Key Discussion Areas:
- Improving access, participation and uptake across screening programmes.
- Reducing health inequalities and unwarranted variation.
- Managing workforce and diagnostic capacity pressures.
- Strengthening links between screening, diagnostics and onward care.
- Supporting earlier diagnosis and reducing delays across pathways.
- Improving patient experience and pathway flow.
- How screening services can use population health insight and targeted approaches to reach higher-risk groups.
- What practical changes are needed to make screening pathways more resilient and scalable over the next 12–24 months.
Tea, Coffee & Networking
Got a great question? Ask it during the session for a chance to win a voucher for the best audience question.
End of Day
Every attendee makes a difference. We’ll donate one tree for every delegate attending the conference to our partners over at Play it Green and £1 to our Charity of the Year, Stockport Without Abuse.
Book your tickets
Limited places
Limited places
Limited places
